Parallax Volatility Advisers
AMAG

Parallax Volatility Advisers’s AMAG Pharmaceuticals AMAG Stock Holding History

Parallax Volatility Advisers’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40
Closed -$1K – 3921
2018
Q2 		$1K Buy
+40
New +$885 ﹤0.01% 2019
2018
Q1 		– Sell
-5,376
Closed -$71K – 4918
2017
Q4 		$71K Buy
+5,376
New +$81.1K ﹤0.01% 3013

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parallax Volatility Advisers's AMAG Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 40 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in AMAG in Q4 2017 and held it in 2 quarters. The position peaked at $71K in Q4 2017. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

  • Parallax Volatility Advisers reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 40 AMAG Pharmaceuticals shares in Q3 2018, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's AMAG Pharmaceuticals position peaked at $71K in Q4 2017.
  • 182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.